stockrowNeoGenomics, Inc. (NEO) vs Sotera Health Company (SHC)
- NeoGenomics, Inc. NEO 16.49 0.00%
- Sotera Health Company SHC 15.81 −0.38%
NeoGenomics, Inc. and Sotera Health Company are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $4.5B against $2.1B — 2.1× the size. NeoGenomics, Inc. has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 26.3×. NeoGenomics, Inc. grew revenue faster over the last twelve months: 11.1% against 6.90%. Sotera Health Company has the higher net margin (14.1% vs −4.10%) and the higher return on invested capital (9.80% vs −2.97%). Across the 19 metrics below, Sotera Health Company leads on 11 and NeoGenomics, Inc. on 8.
Valuation
Profitability
| Metric | NEO | SHC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 44.77% | 54.62% | 48.32% |
| Operating margin | (6.27%) | 32.66% | (5.68%) |
| Net margin | (4.10%) | 14.11% | (4.10%) |
| Free cash flow margin | (3.37%) | 11.01% | 0.00% |
| Return on equity | (3.94%) | 27.03% | 0.00% |
| Return on assets | (2.35%) | 5.28% | (6.05%) |
| Return on invested capital | (2.97%) | 9.80% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack